DK2114441T3 - Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion - Google Patents

Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion

Info

Publication number
DK2114441T3
DK2114441T3 DK08705122.3T DK08705122T DK2114441T3 DK 2114441 T3 DK2114441 T3 DK 2114441T3 DK 08705122 T DK08705122 T DK 08705122T DK 2114441 T3 DK2114441 T3 DK 2114441T3
Authority
DK
Denmark
Prior art keywords
treatment
alkaline phosphatase
renal impairment
impairment
renal
Prior art date
Application number
DK08705122.3T
Other languages
English (en)
Inventor
Roelof Peter Pickkers
Suzanne Heemskerk
Markwin Paul Velders
Willem Raaben
Marty Bernardus Fransiscus Wulferink
Original Assignee
Am Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Am Pharma Bv filed Critical Am Pharma Bv
Application granted granted Critical
Publication of DK2114441T3 publication Critical patent/DK2114441T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03001—Alkaline phosphatase (3.1.3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK08705122.3T 2007-01-30 2008-01-30 Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion DK2114441T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07101437A EP1952823A1 (en) 2007-01-30 2007-01-30 The use of alkaline phosphatase in the treatment of reduced renal function
PCT/NL2008/050053 WO2008094037A1 (en) 2007-01-30 2008-01-30 The use of alkaline phosphatase in the treatment of reduced renal function

Publications (1)

Publication Number Publication Date
DK2114441T3 true DK2114441T3 (da) 2013-01-21

Family

ID=38002159

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08705122.3T DK2114441T3 (da) 2007-01-30 2008-01-30 Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion

Country Status (11)

Country Link
US (1) US8586032B2 (da)
EP (2) EP1952823A1 (da)
JP (2) JP5580052B2 (da)
CN (3) CN101678085A (da)
AU (1) AU2008211829B2 (da)
CA (1) CA2676968C (da)
DK (1) DK2114441T3 (da)
ES (1) ES2397293T3 (da)
HK (2) HK1204925A1 (da)
PL (1) PL2114441T3 (da)
WO (1) WO2008094037A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110142817A1 (en) * 2004-02-04 2011-06-16 Pharmaaware Sepsis B.V. Means and method for treating and/or preventing necrotizing enterocolitis
JP4999467B2 (ja) 2004-02-04 2012-08-15 ファルマアウェア セプシス ビー．ブイ． 粘膜関門に存在するｌｐｓを解毒するためのアルカリホスファターゼの使用
EP1952823A1 (en) 2007-01-30 2008-08-06 AM-Pharma B.V. The use of alkaline phosphatase in the treatment of reduced renal function
EP1985697A1 (en) * 2007-04-27 2008-10-29 AM-Pharma B.V. Modified phosphatases
WO2010025267A2 (en) 2008-08-29 2010-03-04 The General Hospital Corporation Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
CA2735590A1 (en) * 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US8932587B2 (en) 2010-02-12 2015-01-13 The General Hospital Corporation Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
RU2013133933A (ru) 2010-12-20 2015-01-27 Конинклейке Филипс Электроникс Н.В. Интерфейс пациента, имеющий оборачиваемое оголовье из ткани
EP3222286B1 (en) * 2011-06-08 2020-10-21 AM-Pharma B.V. The use of alkaline phosphatase for preserving renal function
ES2810813T3 (es) * 2014-01-24 2021-03-09 Am Pharma Bv Procesamiento para recuperación y purificación de una fosfatasa alcalina
CA2937328C (en) 2014-01-24 2022-09-27 Am-Pharma B.V. Chimeric alkaline phosphatase-like proteins
WO2018175413A1 (en) 2017-03-21 2018-09-27 Synthetic Biologics, Inc. Alkaline phosphatase formulations
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
FI3762018T3 (fi) 2018-03-08 2024-04-22 Am Pharma Bv Rekombinantti alkalinen fosfataasi käytettäväksi sepsikseen liittyvän akuutin munuaisvaurion hoitamiseen
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
US11654184B2 (en) 2018-03-20 2023-05-23 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
JP7660523B2 (ja) 2019-05-06 2025-04-11 セリバ・バイオロジクス・インコーポレイテッド アルカリリン酸塩に基づいた癌治療
CN112760305B (zh) * 2021-01-25 2022-04-29 浙江工业大学 一种栖热腔菌磷酸酶突变体及其应用
CN115990245B (zh) * 2022-07-15 2025-04-01 中山大学附属第一医院 一种含肠型碱性磷酸酶的抗腹膜纤维化透析液的制备方法
JP2026511077A (ja) * 2023-03-21 2026-04-10 アーエム－ファルマ ベー．フェー． 慢性腎障害の急性増悪を治療することにおける使用のためのアルカリホスファターゼ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176709A1 (en) * 1993-11-15 1995-05-26 Howard R. Higley Method of treating renal disease by administering igf-i and igfbp-3
DE60120007T2 (de) * 2000-01-31 2006-11-16 Pfizer Products Inc., Groton Verwendung von Aktivatoren des Prostaglandinrezeptores 4 zur Behandlung von akuter oder chronischer Niereninsuffizienz
CN1425766A (zh) 2001-12-19 2003-06-25 复旦大学 一种多肽——人含碱性磷酸酶活性位点的蛋白－9.24和编码这种多肽的多核苷酸
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
JP4999467B2 (ja) * 2004-02-04 2012-08-15 ファルマアウェア セプシス ビー．ブイ． 粘膜関門に存在するｌｐｓを解毒するためのアルカリホスファターゼの使用
EP1952823A1 (en) 2007-01-30 2008-08-06 AM-Pharma B.V. The use of alkaline phosphatase in the treatment of reduced renal function

Also Published As

Publication number Publication date
CN106466476A (zh) 2017-03-01
JP5580052B2 (ja) 2014-08-27
CN101678085A (zh) 2010-03-24
CA2676968C (en) 2015-06-16
HK1204925A1 (en) 2015-12-11
CA2676968A1 (en) 2008-08-07
HK1232161A1 (zh) 2018-01-05
CN104189896A (zh) 2014-12-10
US20100111923A1 (en) 2010-05-06
JP2010516808A (ja) 2010-05-20
ES2397293T3 (es) 2013-03-06
JP5734482B2 (ja) 2015-06-17
AU2008211829B2 (en) 2012-09-13
EP1952823A1 (en) 2008-08-06
EP2114441B1 (en) 2012-10-17
US8586032B2 (en) 2013-11-19
WO2008094037A1 (en) 2008-08-07
PL2114441T3 (pl) 2013-03-29
JP2014139202A (ja) 2014-07-31
EP2114441A1 (en) 2009-11-11
AU2008211829A1 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
DK2114441T3 (da) Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion
EP2049713A4 (en) tissue rejection
DE602008005653D1 (de) Femurtrochlea-Prothese
IL246421A0 (en) Self-expanding devices
BRPI0812536A2 (pt) Prótese de núcleo
DK2166887T3 (da) Filter
DE602008002748D1 (de) Linseneinführsystem
EP2173353A4 (en) Transplants
EP2121110A4 (en) BIOKOMPATIBLE WUNDAUFLAGE
BRPI0814860A2 (pt) Elementos de filtro
PL2124831T3 (pl) Urządzenia protetyczne
BRPI0815527A2 (pt) "filtro"
BRPI0819073A2 (pt) fralda descartável
DK2175851T3 (da) Biofilmbehandling
DK2200600T3 (da) Neramexan til anvendelse ved behandlingen af subakut tinnitus
BRPI0811008A2 (pt) Conjunto de filtro
DE602008006709D1 (de) Funduskamera
BRPI0819071A2 (pt) fralda descartável
BRPI0815815A2 (pt) Obturador de múltiplos estágios
KR100788052B9 (ko) 샤워 필터 장치
DK2165051T3 (da) Filterelementer
DE112008002814A5 (de) Orthesengelenk
DK1715723T3 (da) Höresystem med netværkstid
BRPI0820217A2 (pt) Filtro
DK2001499T3 (da) Anvendelse af TGS-6 til behandling af osteoporose